Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enveric Biosciences
AddedFeb 20, 2024
UpdatedJun 18, 2026
Enveric Biosciences

Enveric Biosciences

Public

Enveric Biosciences: A patient-centric biotech firm, innovating natural compounds for cancer treatment side effects.

HQ
Naples, FL, US
Founded
1994
Overview
Compare
Fundraising
Employees
Website

Enveric Biosciences, founded with a mission to enhance patient lives, is a biotechnology company focused on developing novel neuroplastogenic small-molecule therapeutics for neuropsychiatric disorders. Initially targeting the side effects of cancer treatments using natural compounds like cannabinoids, Enveric has evolved to leverage its unique discovery and development platform, The Psybrary™, to create a robust Intellectual Property portfolio of New Chemical Entities aimed at specific mental health conditions.

Notable figures affiliated with Enveric Biosciences include key industry experts and investors who have supported its innovative approach. The company has achieved significant milestones in expanding its IP portfolio and advancing its therapeutic candidates through rigorous testing. Enveric's impact lies in its commitment to addressing unmet medical needs, particularly in mental health, positioning itself as a leader in the biotech space dedicated to improving patient outcomes through cutting-edge science.

Enveric Biosciences - Quick Facts

When was Enveric Biosciences founded?

Enveric Biosciences was founded in 1994.

Where is Enveric Biosciences' headquarters located?

Enveric Biosciences' headquarters is located in Naples, FL, US.

When was Enveric Biosciences' last funding round?

Enveric Biosciences' most recent funding round was for $1.8M (USD) in December 2023.

How much has Enveric Biosciences raised to-date?

As of Dec 29, 2023, Enveric Biosciences has raised a total of $42.6M (USD).

How many employees does Enveric Biosciences have?

Enveric Biosciences has 375 employees as of Feb 6, 2024.

Enveric Biosciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Main Product
  • Therapeutics
Tags
  • Biotech
  • Healthcare
Unique IDs
  • ein: 954484725
  • secCik: 0000890821
  • ticker: ENVB
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 334400Semiconductor and Other Electronic Component Manufacturing
  • 334413Semiconductor and Related Device Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 334410Semiconductor and Other Electronic Component Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3674Semiconductors And Related Devices
  • 3600Electronic And Other Electrical Equipment And Components, Except Computer
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 3670Electronic Components And Accessories
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2610Manufacture of electronic components and boards